LPL Financial’s Trevi Therapeutics TRVI Stock Holding History

LPL Financial’s Portfolio TRVI Stock Details TRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$957K	Buy	66,838 +3,389	+5%	+$58.3K	﹤0.01%	4557
2026 Q2	$1.18M	Sell	63,449 -17,434	-22%	-$254K	﹤0.01%	4282
2026 Q1	$965K	Buy	80,883 +27,923	+53%	+$313K	﹤0.01%	4213
2025 Q4	$663K	Buy	52,960 +12,510	+31%	+$145K	﹤0.01%	4460
2025 Q3	$370K	Buy	40,450 +28,550	+240%	+$214K	﹤0.01%	4877
2025 Q2	$65.1K	Buy	+11,900	New	+$74K	﹤0.01%	5336
2025 Q1	–	Sell	-36,000	Closed	-$148K	–	5519
2024 Q4	$148K	Hold	36,000	–	–	﹤0.01%	4899
2024 Q3	$120K	Hold	36,000	–	–	﹤0.01%	4858
2024 Q2	$107K	Hold	36,000	–	–	﹤0.01%	4731
2024 Q1	$124K	Buy	+36,000	New	+$80.3K	﹤0.01%	4632
2023 Q3	–	Sell	-10,000	Closed	-$23.9K	–	4795
2023 Q2	$23.9K	Hold	10,000	–	–	﹤0.01%	4503
2023 Q1	$18.5K	Hold	10,000	–	–	﹤0.01%	4418
2022 Q4	$19.3K	Sell	10,000 -10,000	-50%	-$19.7K	﹤0.01%	4372
2022 Q3	$31K	Buy	20,000 +10,000	+100%	+$32.8K	﹤0.01%	4288
2022 Q2	$28K	Hold	10,000	–	–	﹤0.01%	4306
2022 Q1	$22K	Hold	10,000	–	–	﹤0.01%	4119
2021 Q4	$8K	Hold	10,000	–	–	﹤0.01%	4326
2021 Q3	$14K	Hold	10,000	–	–	﹤0.01%	4307
2021 Q2	$23K	Hold	10,000	–	–	﹤0.01%	4188
2021 Q1	$27K	Hold	10,000	–	–	﹤0.01%	4035
2020 Q4	$24K	Hold	10,000	–	–	﹤0.01%	3774
2020 Q3	$40K	Hold	10,000	–	–	﹤0.01%	3452
2020 Q2	$66K	Buy	+10,000	New	+$35.2K	﹤0.01%	3334

Other funds holding TRVI

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

LPL Financial's TRVI Position: Q3 2026 in Review

LPL Financial increased its Trevi Therapeutics (TRVI) stake by 5.3% in Q3 2026, buying an estimated $58.3K and bringing the position to 66,838 shares worth $957K. The position accounts for ﹤0.01% of the portfolio, ranked #4557.

LPL Financial first reported a position in TRVI in Q2 2020 and has held it in 23 quarters since. The position peaked at $1.18M in Q2 2026. 90 funds tracked by Wall St. Rank hold TRVI as of Q3 2026.

LPL Financial held 66,838 shares of Trevi Therapeutics worth $957K as of Q3 2026.
LPL Financial bought 3,389 Trevi Therapeutics shares in Q3 2026, an estimated $58.3K.
Trevi Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q3 2026, its #4557 holding.
LPL Financial first reported a position in Trevi Therapeutics in Q2 2020 and has held it in 23 quarters since.
LPL Financial's Trevi Therapeutics position peaked at $1.18M in Q2 2026.
90 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q3 2026.

Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.